Pharmaceutical PV DIV - FSB
Ended Awarded Last action
- Contract number
- SPE2DU26FELRN
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $17,629
Award facts
- Contract value 100% obligated
- $17,628.86 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $17,628.86 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois. This delivery order was issued without a set-aside designation and carries an ultimate completion date of January 12, 2026. DMS Pharmaceutical Group is a specialized supplier within the federal pharmaceutical supply chain, distributing a comprehensive range of products including branded and generic prescription medications, biologics, vaccines, specialty pharmaceuticals, and medical consumables to support Department of Defense healthcare operations.
This delivery order is issued under DMS Pharmaceutical Group's Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy designed to provide pharmaceutical products to military healthcare facilities worldwide. The underlying IDC, designated SPE2DR and awarded November 13, 2025, carries a $499,999,999 ceiling value and extends through December 31, 2036, with a 30-month base period and three 30-month option periods. DMS Pharmaceutical Group operates as one of multiple regional prime vendor contractors under this program, enabling the Defense Logistics Agency to issue firm fixed-price delivery orders for pharmaceutical products supporting recurring medical supply needs across the global military healthcare system.
Quick answers
Who was awarded contract SPE2DU26FELRN?
SPE2DU26FELRN was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 9, 2026.
How much is contract SPE2DU26FELRN worth?
The government has obligated $17,629 on SPE2DU26FELRN.
Is contract SPE2DU26FELRN an order under another contract?
Yes. SPE2DU26FELRN is a delivery order under SPE2DU25D9421, an indefinite delivery contract.
Was contract SPE2DU26FELRN competed?
The extent of competition for SPE2DU26FELRN was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award